99
Views
44
CrossRef citations to date
0
Altmetric
Original Article

In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR)

, , , , , & show all
Pages 607-621 | Received 22 Feb 2000, Published online: 07 Jul 2009

References

  • Henrotin Y.E., Labasse A.H., Simonis P.E., Zheng S.X., Deby G.P., Famaey J-P., Crielaard J-M.R., Reginster J-Y.L. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro. Clinical and Experimental Rheumatology 1999; 17: 151–160
  • Pelletier J-P., Mineau F., Fernandes J., Kiansa K., Ranger P., Martel-Pelletier J. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts. Clinical and Experimental Rheumatology 1997; 15: 393–398
  • Dreiser R.L., Benevelli D.C. Long term tolerability profile of nimesulide in the treatment of osteoarthritis. Drugs 1993; 46: 270–274
  • Famaey J-P. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview. Inflammation Research 1996; 46: 437–446
  • Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proceedings of the National Academy of Sciences of the United States of America 1994; 90: 11693–11697
  • Wober W. Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide. Rheumatology 1999; 38: 33–38
  • Maffei F.R., Caranini M., Aldini G., Saibene L., Macciocchi A. Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PLC) as membrane model. International Journal of Tissue Reactions 1993; 15: 225–234
  • Cappecchi P.L., Ceccatelli L., Beermann U., Laghi P.L., Di Perri T. Inhibition of neutrophil function in vitro by nimesulide. Preliminary evidence of an adenosine-mediated mechanism. Arzneimittel-Forschung 1993; 43: 992–996
  • Ribeiro C.A., Figeuiredo A., Tavares P., Poiares-Baptista A., Teixeria F. Tiaprofenic acid-induced photohemolysis in vitro is inhibited by nimesulide. Drug Metabolism and Drug Interactions 1992; 10: 293–305
  • Bevilacqua M., Vago T., Baldi G., Renesto E., Dallegri F., Norblato G. Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV. European Journal of Pharmacology 1994; 268: 415–423
  • Dallegri F., Patrone F., Ballestrero A., Ottonello L., Ferrando F., Sacchetti C. Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation. International Journal of Tissue Reactions 1990; 12: 107–111
  • Maffei-Facino R., Carini M., Aldini G. Antioxidant activity of nimesulide and its main metabolites. Drugs 1993; 46(Suppl 1)15–21
  • Maffei F.C., Carini M., Aldini G., Saibene L., Morelli M. Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulide. Arzneimittel-Forschung 1995; 45: 1102–1109
  • Guillen C., McInnes I.B., Kruger H., Brock J.H. Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response. Annals of the Rheumatic Diseases 1998; 57: 309–314
  • Guillen C., McInnes I.B., Brock J.H. Iron in synovial fluid: removal by lactoferrin, and relationship to iron regulatory protein (IRP) activity. Biochemical Society Transactions 1997; 25: 315S–315S
  • Dabbagh A.J., Trenam C.W., Morris CJ C.J., Blake D.R. Iron in joint inflammation. Annals of the Rheumatic Diseases 1993; 52: 67–73
  • Rister M., Bauermeister K., Gravert U., Gladtke E. Superoxide-dismutase deficiency in rheumatoid arthritis. Lancet 1978; i: 1094–1094
  • Aaseth J., Haugen M., Forre O. Rheumatoid arthritis and metal compounds — perspectives on the role of oxygen radical detoxification. Analyst 1998; 123: 3–6
  • Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production of peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 1990; 87: 1620–1624
  • Oh M., Fukuda K., Asada S., Yasuda Y., Tanaka S. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite. Journal of Rheumatology 1998; 25: 2169–2174
  • Jang D., Murrell G.A.C. Nitric oxide in arthritis. Free Radical Biology and Medicine 1998; 24: 1511–1519
  • Whiteman M., Kaur H., Halliwell B. Protection against peroxynitrite dependent tyrosine nitration and alpha 1-antiproteinase inactivation by some antiinflammatory drugs and by the antibiotic tetracycline. Annals of Rheumatologic Diseases 1996; 55: 383–387
  • Ottonello L., Dapino P., Scriocco M.C., Balbi A., Bevilacqua M., Dallegri P. Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation?. Clinical Science 1995; 88: 331–336
  • Schiller J., Arnhold J., Schwinn J., Sprinz H., Brede O., Arnold K. Reactivity of cartilage and selected carbohydrates with hydroxyl radicals. An NMR study to detect degradation products. Free Radical Research 1998; 28: 215–228
  • Green M.J., Hill H.A. Oxygen Radicals in Biological Systems. Methods in Enzymology 1984; 105: 3–22
  • Borgeat P., Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proceedings of the National Academy of Sciences od the United States of America 1979; 76: 2148–2152
  • Uppu R.M., Squadrito G.L., Cueto R., Pryor W.A. Selecting the most appropriate synthesis of peroxynitrite. Methods in Enzymology 1996; 269: 311–321
  • Kissner R., Nauser T., Bugnon P., Lye P.G., Koppenol W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chemical Research in Toxicology 1997; 10: 1285–1292
  • Davis R., Brogden R.N. Nimesulide. An update of its pharmacodynamic and pharmacokinetic efficacy. Drugs 1994; 48: 431–454
  • Areenwald G.R., Moxx W.W. Inhibition of collagen gelation by action of superoxide radical. Arthritis and Rheumatism 1979; 22: 251–259
  • Imlay J.A., Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 1302–1304
  • Burkhardt H., Schwingel M., Menninger H., Macartney H.W., Tschesche H. Oxygen radicals as effectors of cartilage degradation. Arthritis and Rheumatism 1986; 29: 379–387
  • Carp H., Janoff A. Potential mediator of inflammation: phagocyte derived oxidants suppress the elastase inhibitory capacity of α1-proteinase inhibitor in vitro. Journal of Clinical Investigation 1980; 66: 987–995
  • Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393–397
  • Dallegri F., Ottenello L., Dapino P., Sacchetti C. Effect of nonsteroidal antiinflammatory drugs on the neutrophil promoted inactivation of alpha-1-proteinase inhibitor. Journal of Rheumatology 1992; 19: 419–423
  • Ottonello L., Dapino P., Pastorino G., Montagnani G., Gatti F., Guidi G., Dallegri F. Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Drugs 1993; 46(Suppl 1)29–33
  • Zheng S.X., Mouithys-Mickalad A., Deby-Dupont G., Deby C., Maroulis A., Labasse A., Lamy M., Crielaard J-M., Reginster J-Y., Henrotin Y. In vitro study of the antioxidant properties of nimesulide and 4-HO nimesulide: Effects on HRP-and luminol-dependent chemiluminescence produced by human chondrocytes. Osteoarthritis and Cartilage 2000, in press
  • Bevilacqua M., Eagni M. Recent contribution to knowledge of the mechanism of action of nimesulide. Drugs 1993; 46(Suppl 1)40–47
  • Nandgaonkar B., Rotschild T., Yu K., Higgins R. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatric Research 1999; 46: 184–188
  • Carreras C.M., Pargament G.A., Catz S.D., Poderoso J.J., Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Letters 1994; 341: 65–68
  • Gagnon C., Leblond F.A., Filep J.G. Peroxynitrite production by human neutrophils, monocytes and lymphocytes challenged with lipopolysaccharide. FEBS Letters 1998; 431: 107–110
  • Deby-Dupont G., Deby C., Lamy M. Neutrophil myeloperoxidase revisited: it's role in health and disease. Intensivmedizin 1999; 36: 500–513
  • Winterbourn C.C., Brennan S.O. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochemical Journal 1997; 326: 87–92
  • Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. American Journal of Physiology 1995; 268: L699–722
  • Arteel G.E., Briviba K., Sies H. Protection against peroxynitrite. FEBS Letters 1999; 45: 226–230

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.